Speaker: Richard Kay: RK Statistics Ltd, Great Longstone, UK
On assessing the presence of evaluation-time bias in progression-free survival in randomized trials
Co-authors: Jane Wu, Janet Wittes
Published Online: Jun 21 2010
Speaker: Gui-shuang Ying: Department of Ophthalmology, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Weibull prediction of event times in clinical trials
Co-author: Daniel F. Heitjan
Pharmaceutical Statistics, Volume 7, Issue 2, pages 107-120, April/June 2008 Abstract | Paper+ | Slides
+ Papers available to view from 20th October 2010 to 17th November 2010.
For a flier advertising the event, please click here.
Joint PSI, EFSPI & ASA BIOP Webinar: Estimands
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.